Oncodesign Precision Medicine Société anonyme Balance Sheet Health
Financial Health criteria checks 3/6
Oncodesign Precision Medicine Société anonyme has a total shareholder equity of €3.7M and total debt of €8.8M, which brings its debt-to-equity ratio to 239.2%. Its total assets and total liabilities are €16.6M and €12.9M respectively.
Key information
239.2%
Debt to equity ratio
€8.83m
Debt
Interest coverage ratio | n/a |
Cash | €10.34m |
Equity | €3.69m |
Total liabilities | €12.94m |
Total assets | €16.63m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ALOPM's short term assets (€14.4M) exceed its short term liabilities (€4.1M).
Long Term Liabilities: ALOPM's short term assets (€14.4M) exceed its long term liabilities (€8.9M).
Debt to Equity History and Analysis
Debt Level: ALOPM has more cash than its total debt.
Reducing Debt: Insufficient data to determine if ALOPM's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if ALOPM's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if ALOPM's interest payments on its debt are well covered by EBIT.